CSF biomarker variability in the Alzheimer's Association quality control program

Niklas Mattsson, Ulf Andreasson, Staffan Persson, Maria C Carrillo, Steven Collins, Sonia Chalbot, Neal Cutler, Diane Dufour-Rainfray, Anne M Fagan, Niels Henrik Helweg Heegaard, Ging-Yuek Robin Hsiung, Bradley Hyman, Khalid Iqbal, D Richard Lachno, Alberto Lleó, Piotr Lewczuk, José L Molinuevo, Piero Parchi, Axel Regeniter, Robert RissmanHanna Rosenmann, Giuseppe Sancesario, Johannes Schröder, Leslie M Shaw, Charlotte E Teunissen, John Q Trojanowski, Hugo Vanderstichele, Manu Vandijck, Marcel M Verbeek, Henrik Zetterberg, Kaj Blennow, Stephan A Käser, Alzheimer's Association QC Program Work Group

Research output: Contribution to journalJournal articleResearchpeer-review

255 Citations (Scopus)
Original languageEnglish
JournalAlzheimer's & Dementia
Volume9
Issue number3
Pages (from-to)251-261
Number of pages11
ISSN1552-5260
DOIs
Publication statusPublished - May 2013
Externally publishedYes

Keywords

  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Biological Markers
  • Chemistry, Clinical
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Laboratories, Hospital
  • Peptide Fragments
  • Phosphorylation
  • Quality Control
  • Reproducibility of Results
  • Societies, Medical
  • tau Proteins

Fingerprint Dive into the research topics of 'CSF biomarker variability in the Alzheimer's Association quality control program'. Together they form a unique fingerprint.

Cite this